SCHEMBL19644599

SCHEMBL19644599

N#C[C@]1(CO)O[C@@H](c2csc3c(N)ncnc23)C(N=[N+]=[N-])[C@@H]1O

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17453489 1.00 HIF1A (0.35) HIF1AALDH1A1
SCHEMBL21136376 0.85 HIF1A (0.32) HIF1AALDH1A1
SCHEMBL17453478 0.84 HIF1A (0.37) HIF1A
SCHEMBL19644598 0.83 HIF1A (0.34) HIF1A
SCHEMBL19644605 0.83 HIF1A (0.36) HIF1AALDH1A1
SCHEMBL21880798 0.83 HIF1A (0.36) HIF1AALDH1A1
SCHEMBL17453462 0.83 HIF1A (0.36) HIF1AALDH1A1
SCHEMBL17453476 0.82 HIF1A (0.34) HIF1A
SCHEMBL21880481 0.82 HIF1A (0.35) HIF1AALDH1A1
SCHEMBL19644632 0.82 HIF1A (0.35) HIF1AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4023650-A1 4'-SUBSTITUTED-FURO[3,2-D]PYRIMIDINE AND -PYRROLO[3,2- D]PYRIMIDINE DERIVATIVES USEFUL FOR TREATING RESPIRATORY SYNCITIAL VIRUS INFECTIONS Gilead Sciences, Inc. (US) 2022-07-06 — — EP disclosed
EP-3174870-B1 THIENO [3,2-D]PYRIMIDINES, FURO [3,2,D]PYRIMIDINES AND PYRROLO [3,2-D]PYRIMIDINES USEFUL FOR TREATING RESPIRATORY SYNCITIAL VIRUS INFECTIONS GILEAD SCIENCES INC (US) 2020-04-15 — — EP disclosed
US-9828388-B2 Thieno[3,2-d]pyrimidine, furo[3,2-d]pyrimidine, and pyrrolo[3,2-D]pyrimidines useful for treating respiratory syncitial virus infections GILEAD SCIENCES, INC. (US) 2017-11-28 — — US disclosed
Send feedback